Literature DB >> 22087186

Advances of interventional radiology in treatment of hepatobiliary diseases in Iran.

Hossein Ghanaati1, Kavous Firouznia, Amir Hossein Jalali, Madjid Shakiba.   

Abstract

Interventional radiologists are physicians who specialize in minimally invasive targeted therapies, offering the most in-depth knowledge of the less invasive therapies that are available and diagnostic and clinical experience across all specialties. Interventional radiologists offer treatments for hepatobiliary diseases without significant side effects or damage to the adjacent normal tissue. We briefly introduce some of the interventional procedures in gastroenterology.

Entities:  

Keywords:  Biopsy; Hepatocellular carcinoma; Interventional radiology; Portasystemic shunt; Transjugular intrahepatic

Year:  2011        PMID： 22087186      PMCID： PMC3212764     

Source DB:  PubMed          Journal:  Hepat Mon        ISSN： 1735-143X            Impact factor:   0.660


  8 in total

Review 1.  Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives.

Authors:  J Rösch; F S Keller
Journal:  World J Surg       Date:  2001-04-11       Impact factor: 3.352

2.  Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-center study.

Authors:  Qingle Zeng; Yanhao Li; Yong Chen; Yong Ouyang; Xiang He; Heping Zhang
Journal:  Cardiovasc Intervent Radiol       Date:  2004-07-30       Impact factor: 2.740

Review 3.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Same day outpatient transjugular liver biopsies in haemophilia.

Authors:  S Saab; D Cho; D V K Quon; A B Ibrahim; P Dong; V Marder; L Logan
Journal:  Haemophilia       Date:  2004-11       Impact factor: 4.287

6.  Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia.

Authors:  M Detrait; D Pothen; R Brenard; P Starkel; C Hermans
Journal:  Haemophilia       Date:  2007-09       Impact factor: 4.287

7.  Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus.

Authors:  Natalie Stieltjes; Nadra Ounnoughene; Emilie Sava; Patricia Paugy; Valérie Roussel-Robert; Arielle R Rosenberg; Benoit Terris; Dominique Salmon-Céron; Philippe Sogni
Journal:  Br J Haematol       Date:  2004-06       Impact factor: 6.998

8.  Nintinol self-expandable metallic stenting in management of malignant obstructive jaundice: a case series.

Authors:  Hossein Ghanaati; Kavous Firouznia; Seyed Mehran Vaziri Bozorg; Ahmad Reza Ghasemi Esfe; Marzieh Motevallei; Mohammad Reza Abedini; Saed Rahmat Sadeghi
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660
  8 in total
  3 in total

1.  Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.

Authors:  Kavous Firouznia; Hossein Ghanaati; Seyed Moayed Alavian; Payam Azadeh; Mohsen Nasiri Toosi; Arya Haj Mirzaian; Safa Najafi; Madjid Shakiba; Amir Hossein Jalali
Journal:  Hepat Mon       Date:  2014-12-28       Impact factor: 0.660

2.  Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Authors:  Hossein Ghanaati; Seyed Moayed Alavian; Ali Jafarian; Nasser Ebrahimi Daryani; Mohsen Nassiri-Toosi; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

3.  How to start interventional radiology.

Authors:  Hossein Ghanaati; Kavous Firouznia; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.